Latest Bioethics Stories
BASEL, Switzerland, September 6, 2014 /PRNewswire/ -- As one of the last airlines of its kind, Air France is ready to take on animal transports for research facilities.
MarketOptimizer.org adds “Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020” to its store.
ENGLEWOOD, Colo., Aug. 25, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.
GREENWICH, Conn., Aug.
Oncothyreon to Leverage Alpine's Protocell Technology to Enable Targeted Delivery of Molecular Therapeutics for Serious Diseases Company to Hold Conference Call at 4:30
NEW YORK, July 29, 2014 /PRNewswire/ -- Recently unveiled at the annual American Society of Clinical Psychopharmacology conference in Hollywood, FL, a new randomized, double-blinded, placebo-controlled
Expanding bio-risk management support for federal, state and institutional laboratories PRINCETON, N.J., July 24, 2014 /PRNewswire/ -- WIRB-Copernicus Group(®) ("WCG")(TM), the world's
Investigators at The Feinstein Institute for Medical Research have utilized a new image-based strategy to identify and measure placebo effects in randomized clinical trials for brain disorders.
BASEL, Switzerland, July 18, 2014 /PRNewswire/ -- The Basel Declaration presented the Award for Education in Animal Research for the third consecutive year.
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.
More Images (1 images) »